Terms And Conditions
  1. Home
  2. Terms And Conditions
Pacific Edge Limited (ASX: PEB) Raises NZ$25....
By ACE Investors / 21 May 2026
Read More
Blinklab Limited (ASX: BB1): Significantly st...
By ACE Investors / 20 May 2026
Read More
Repligen Corporation (NASDAQ: RGEN): Focused ...
By ACE Investors / 20 May 2026
Read More
Medtronic PLC (NYSE: MDT): Strengthened its e...
By ACE Investors / 18 May 2026
Read More
Biomarin Pharmaceutical Inc (NASDAQ: BMRN): R...
By ACE Investors / 15 May 2026
Read More
Zoetis Inc. (NASDAQ: ZTS): Strategic pursuit ...
By ACE Investors / 14 May 2026
Read More
Monash IVF Group Limited (ASX: MVF): Operatio...
By ACE Investors / 12 May 2026
Read More
GE HealthCare Technologies Inc. (NASDAQ: GEHC...
By ACE Investors / 11 May 2026
Read More
NRx Pharmaceuticals, Inc. (NASDAQ: NRXP): Tra...
By ACE Investors / 11 May 2026
Read More
Eli Lilly and Company (NYSE: LLY): Strategica...
By ACE Investors / 07 May 2026
Read More
Fisher & Paykel Healthcare Corp Limited (ASX:...
By ACE Investors / 04 May 2026
Read More
Gilead Sciences, Inc. (NASDAQ: GILD) – Lead...
By ACE Investors / 01 May 2026
Read More
ABN No: 70 637 702 188 | ACN NO: 637 702 188
Copyright © 2025 ACE Investors. All Right Reserved. Design by Ace Investors